Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tuberculosis Prevention in HIV-Infected Patients With Anergy
NCT00402610Phase 4Completed
- Sponsor
- Sociedad Andaluza de Enfermedades Infecciosas
- Start
- Jan 1994
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of isoniazid, rifampicin, pyrazinamide in Tuberculosis (TB), sponsored by Sociedad Andaluza de Enfermedades Infecciosas. Started Jan 1994; status: completed.
02
Drugs
isoniazidrifampicinpyrazinamide
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT00402610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00402610.